Related Experiment Videos
A pilot study of treatment of social phobia with alprazolam
The American Journal of Psychiatry
|May 1, 1988
Abstract:
Fourteen patients with DSM-III social phobia were treated with alprazolam in an open study. Multiple measures of symptoms and disability showed significant improvement. The symptoms improved during the first and second weeks, and disability improved at 3 weeks and beyond. After medication withdrawal the symptom and disability measures were no longer significantly different from those at baseline.